LLY
Eli Lilly and Company$1,199.43-2.48% 1D· price as of Jun 30, 8:32 PM+50.85% over 1Y
Compare:LLY
Mkt Cap
$1.07T
P/E
42.6×
Fwd P/E
27.0×
PEG
1.56
P/B
34.4×
P/S
14.8×
EV/EBITDA
30.6×
Beta
0.52
Div Yield
0.6%
Payout
22.1%
ROE
107.5%
Net Margin
35.0%
Short % Flt
1.1%
Inst. Own
85.4%
52-wk low $623.78$1,199.4352-wk high $1,238.00
+92.3% above low-3.1% from high
Seasonality — avg monthly return
Strongest Jun 9.2% · weakest Jul -2.3%Jan
+3.1
Feb
+3.7
Mar
-0.6
Apr
+4.3
May
+5.1
Jun
+9.2
Jul
-2.3
Aug
+7.5
Sep
-2.0
Oct
+6.4
Nov
+5.4
Dec
+1.1
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Eli Lilly and Company
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
LLY — recent news
Loading headlines…
Quality scorecard
vs Pharmaceuticals · 7 peers · percentile rank
75 / 100
Strong
ROIC34.5%
100
ROE77.8%
83
Gross margin83.0%
100
Operating margin45.6%
100
FCF yield0.6%
0
Net debt / EBITDA1.1×
67
Percentile vs 7 Pharmaceuticals peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.